OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $65,000 Invested

2007

University of North Carolina at Pembroke

Ben Bahr, PhD

In vitro testing of new lysosomal modulatory drugs for reducing tau aggregates in a hippocampal slice model

  • Funding Amount: $65,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed